Mohamed Saad Elzahy

Metronomic Low Dose Leucovorin- Fluorouracil versus Supportive Treatment for Patients with Recurrent or Metastatic Colorectal Cancer

Hend M. Hamdey Rashed Elkalla, Mohamed Saad Elzahy & Shoukri Hassan Elazab · Journal of Cancer and Tumor International · 2019

Introduction: There was an improvement in therapeutic regimens for advanced colorectal cancer (CRC) in the last few decades. The low dose metronomic palliative chemotherapy in patients with advanced CRC after the failure of standard chemotherapy led to a dramatic increase in effi...

Open access Research Article 10.9734/jcti/2019/v9i130101

Three Cycles versus Six Cycles of Neoajuvant Chemotherapy in Stage II and III Breast Cancer: 3 Years Overview

Shoukri Hassan Elazab, Mohamed Saad Elzahy & Shimaa E. Attia · International Research Journal of Oncology · 2019

Background: The majority of breast cancer patients is diagnosed at a young age and present with locally advanced stage which limit the response to treatment and the frequency of conservative surgery. Neoadjuvant chemotherapy increasingly used to achieve better results. The number...

Open access Research Article